【Objective】 Through exploring the intellectual characteristics of patients with congenital hypothyroidism(CH) diagnosed by neonatal screening program and analyzing the relations between intelligence and the disease itself or therapy factors, and to provide a basis for more exactly evaluating the outcomes and exploring more perfect therapeutic schedule. 【Methods】 The subjects were the CH patients aged from 7 to 18 years old. Intelligence tests were completed in all patients using China Wechsler intelligence scale for children(C-WISC). The patients' intelligence quotients were compared with those of normal population. Statistic analyzing was conducted using the SPSS 13.0 statistic software for Windows. 【Results】 The difference between intelligence quotients(IQ) of CH patients and standard value of normal population(100±15) was not significant(P>0.05). The IQ of CH patients had significant or very significant positive correlation with T4 concentrations at the time of CH were diagnosed, the severity of thyroid gland hypoplasia, level of restoring thyroid function at the beginning of therapy(r=0.336~0.660, P=0.024~0.000) and a negative correlation with the age of initial treatment(r=0.295,P=0.049). 【Conclusions】 The intelligence distribution characteristic of CH patients is consistent with the normal population. The important factors affecting the intellectual development in CH patients were severity of CH and level of restoring thyroid function at the beginning of therapy.
Key words
congenital hypothyroidism /
intelligence test /
intelligence quotient
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Beate O, Kietil S, Bengt FK, et al. Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults[J]. Pediatrics,2003,112(4):923-930.
[2] Kempers MJE, Van der Sluijs Veer L, Nijhuis-van der Sanden MWG, et al. Intellectual and motor development of young adults with congenital hypothyroidism diagnosed by neonatal Screening[J]. J Clin Endocrinol Metab,2006,91(2):418-424.
[3] Dimitropoulos A, Molinari L, Etter K, et al. Children with congenital hypothyroidism: long-term intellectual outcome after early high-dose treatment[J]. Pediatr Res,2009,65(2):242-248.
[4] Ng SM, Anand D, Weindling AM. High versus low dose of initial thyroid hormone replacement for congenital hypothyroidism[J]. Cochrane Database Syst Rev,2009,1(1):CD006972.
[5] Mathai S, Cutfield WS, Gunn AJ, et al. A novel therapeutic paradigm to treat congenital hypothyroidism[J]. Clin Endocrinol(Oxf),2008,69(1):142-147.
[6] Delvecchio M, Faienza MF, Acquafredda A, et al. Longitudinal assessment of levo-thyroxine therapy for congenital hypothyroidism: relationship with aetiology, bone maturation and biochemical features[J]. Horm Res,2007,68(3):105-112.
[7] Rose SR, Brown RS.Update of newborn Screening and therapy for congenital hypothyroidism[J]. Pediatrics,2006,117(6):2290-2303.
[8] 杨海河,张玉敏,丁辉.先天性甲状腺功能减低症远期预后的影响因素[J].中国儿童保健杂志,2008,16(3):326-328.
[9] 杨海河,张玉敏,裘蕾,等.先天性甲状腺功能减低症初始治疗结果分析[J].中国儿童保健杂志,2011,18(8):660-663